Page 150 - 2021_09-Haematologica-web

G. Dong et al.
Columbus, OH, USA) for providing us feeder cells for NK-cell stimulation and Ni Feng and Lucy Brown from the City of Hope Analytical Cytometry Core (Duarte, CA, USA) for flow cytometric sorting. Research reported in this publication also included work performed in the Integrative Genomics Core and Gene Editing and Viral Vector Core in City of Hope.
Funding
This project was supported in part by the National Cancer Institute of the National Institutes of Health under grant number P30CA033572. It was also partly supported by the Dr. Norman and Melinda Payson Professorship in Hematologic Cancers and Tony Stephenson Lymphoma Center of City of Hope.
References
1. Yang Y, Cao JZ, Lan SM, et al. Association of improved locoregional control with pro- longed survival in early-stage extranodal nasal-type natural killer/T-cell lymphoma. JAMA Oncol. 2017;3(1):83-91.
2. Li X, Cui Y, Sun Z, et al. DDGP versus SMILE in newly diagnosed advanced natu- ral killer/T-cell lymphoma: a randomized controlled, multicenter, open-labelsStudy in China. Clin Cancer Res. 2016; 22(21):5223-5228.
3. Tse E, Kwong YL. Diagnosis and manage- ment of extranodal NK/T cell lymphoma nasal type. Expert Rev Hematol. 2016; 9(9):861-871.
4.Boi M, Zucca E, Inghirami G, Bertoni F. PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomas. Leuk Lymphoma. 2015;56(5):1223-1228.
5. Kucuk C, Hu X, Jiang B, et al. Global pro- moter methylation analysis reveals novel candidate tumor suppressor genes in natu- ral killer cell lymphoma. Clin Cancer Res. 2015;21(7):1699-1711.
6. Kucuk C, Iqbal J, Hu X, et al. PRDM1 is a tumor suppressor gene in natural killer cell malignancies. Proc Natl Acad Sci U S A. 2011;108(50): 20119-20124.
7. Karube K, Nakagawa M, Tsuzuki S, et al. Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK- cell neoplasms by genomic and functional analyses. Blood. 2011;118(12):3195-3204.
8. Iqbal J, Kucuk C, Deleeuw R, et al. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. Leukemia. 2009;23(6):1139.
9. Boi M, Rinaldi A, Kwee I, et al. PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. Blood. 2013;122(15):2683-2693.
10. Savage HP, Yenson VM, Sawhney SS, et al. Blimp-1-dependent and -independent natu- ral antibody production by B-1 and B-1- derived plasma cells. J Exp Med. 2017;214(9):2777-2794.
11. Cong L, Ran FA, Cox D, et al. Multiplex
genome engineering using CRISPR/Cas
systems. Science. 2013;339(6121):819-823. 12. Dobashi A, Tsuyama N, Asaka R, et al. Frequent BCOR aberrations in extranodal NK/T-cell lymphoma, nasal type. Genes Chromosomes Cancer. 2016;55(5):460-471. 13. Jiang L, Gu ZH, Yan ZX, et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma.
Nat Genet. 2015;47(9):1061-1066.
14. Lee S, Park HY, Kang SY, et al. Genetic alter- ations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lym- phoma nasal type. Oncotarget. 2015;
6(19):17764-17776.
15. Koo GC, Tan SY, Tang T, et al. Janus kinase
3-activating mutations identified in natural killer/T-cell lymphoma. Cancer Discov. 2012;2(7):591-597.
16. Sim SH, Kim S, Kim TM, et al. Novel JAK3- activating mutations in extranodal NK/T- cell lymphoma, nasal type. Am J Pathol. 2017;187(5):980-986.
17. Roth TL, Puig-Saus C, Yu R, et al. Reprogramming human T cell function and specificity with non-viral genome target- ing. Nature. 2018;559(7714):405-409.
18. Ran FA, Hsu PD, Wright J, et al. Genome engineering using the CRISPR-Cas9 sys- tem. Nat Protoc. 2013;8(11):2281-2308.
19. Mian MF, Lauzon NM, Andrews DW, et al. FimH can directly activate human and murine natural killer cells via TLR4. Mol Ther. 2010;18(7):1379-1388.
20. Stolberg VR, Martin B, Mancuso P, et al. Role of CC chemokine receptor 4 in natural killer cell activation during acute cigarette smoke exposure. Am J Pathol 2014; 184(2):454-463.
21. Chen WS, Kitson RP, Goldfarb RH. Modulation of human NK cell lines by vas- cular endothelial growth factor and recep- tor VEGFR-1 (FLT-1). In Vivo. 2002; 16(6):439-445.
22. Vong QP, Leung WH, Houston J, et al. TOX2 regulates human natural killer cell development by controlling T-BET expres- sion. Blood. 2014;124(26):3905-3913.
23. Kallies A, Carotta S, Huntington ND, et al. A role for Blimp1 in the transcriptional net- work controlling natural killer cell matura-
tion. Blood. 2011;117(6):1869-1879.
24. Chihara N, Madi A, Kondo T, et al. Induction and transcriptional regulation of the co-inhibitory gene module in T cells.
Nature. 2018;558(7710):454-459.
25. Kucuk C, Jiang B, Hu X, et al. Activating mutations of STAT5B and STAT3 in lym- phomas derived from gammadelta-T or NK
cells. Nat Commun 2015;6:6025.
26. El-Tayeb A, Iqbal J, Behrenswerth A, et al. Nucleoside-5'-monophosphates as pro- drugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase. J Med
Chem. 2009;52(23):7669-7677.
27. Kucuk C, Hu X, Iqbal J, et al. HACE1 is a
tumor suppressor gene candidate in natural killer cell neoplasms. Am J Pathol. 2013; 182(1):49-55.
28. Demosthenous C, Han JJ, Hu G, et al. Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in dif- fuse large B-cell lymphoma. Oncotarget. 2015;6(42):44703-44713.
29. Sharma Y, Ahmad A, Bashir S, et al. Implication of protein tyrosine phos- phatase SHP-1 in cancer-related signaling pathways. Future Oncol. 2016;12(10):1287- 1298.
30.Yin S, Wu H, Lv J, et al. SHP-1 arrests mouse early embryo development through downregulation of Nanog by dephospho- rylation of STAT3. PloS One 2014; 9(1):e86330.
31. Nakamura MC, Niemi EC, Fisher MJ, et al. Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J Exp Med. 1997; 185(4):673-684.
32. Mahmood S, Kanwar N, Tran J, et al. SHP- 1 phosphatase is a critical regulator in pre- venting natural killer cell self-killing. PloS One. 2012;7(8):e44244.
33. Isobe Y, Sugimoto K, Yang L, et al. Epstein- Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells. Cancer Res. 2004;64(6):2167-2174.
34. Isobe Y, Sugimoto K, Yang L, et al. Epstein- Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells. Cancer Res. 2004;64(6):2167-2174.
2438
haematologica | 2021; 106(9)